117 related articles for article (PubMed ID: 3814224)
21. Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats.
Wang XN; Simmons HA; Salatto CT; Cosgrove PG; Thompson DD
Menopause; 2006; 13(4):609-20. PubMed ID: 16837883
[TBL] [Abstract][Full Text] [Related]
22. Combined action of plant estrogens, F-2 toxin and natural estrogens.
Kallela K
Nord Vet Med; 1978 Mar; 30(3):132-6. PubMed ID: 643543
[TBL] [Abstract][Full Text] [Related]
23. [Quantitative evaluation of steroid extrogens by study of the vaginal epithelium thickness and mitotic index in mice].
Paris J; Thevenot R; Wisniewska T
C R Seances Soc Biol Fil; 1973; 167(6):1004-9. PubMed ID: 4371917
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of estradiol, ethynylestradiol, and moxestrol in rat uterus, vagina, and aorta: influence of sex steroid treatment.
Blom MJ; Wassink MG; Kloosterboer HJ; Ederveen AG; Lambert JG; Goos HJ
Drug Metab Dispos; 2001 Jan; 29(1):76-81. PubMed ID: 11124233
[TBL] [Abstract][Full Text] [Related]
25. Estrogenic activity of standardized extract of Angelica sinensis.
Circosta C; Pasquale RD; Palumbo DR; Samperi S; Occhiuto F
Phytother Res; 2006 Aug; 20(8):665-9. PubMed ID: 16691630
[TBL] [Abstract][Full Text] [Related]
26. Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application.
Elger W; Schwarz S; Hedden A; Reddersen G; Schneider B
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):395-403. PubMed ID: 8541236
[TBL] [Abstract][Full Text] [Related]
27. Estrogenic profile on a water-soluble estrogen, estrazinol hydrobromide.
Rassaert CL; DiPasquale G; Giannina T; Manning JP; Meli A
Steroids Lipids Res; 1973; 4(5):333-40. PubMed ID: 4368700
[TBL] [Abstract][Full Text] [Related]
28. Activity of raloxifene in immature and ovariectomized rat uterotrophic assays.
Ashby J; Odum J; Foster JR
Regul Toxicol Pharmacol; 1997 Jun; 25(3):226-31. PubMed ID: 9237325
[TBL] [Abstract][Full Text] [Related]
29. [Comparative effects of 17 beta-oestradiol and ethinyl-oestradiol on plasma triglycerides in female rats (author's transl)].
Loeper J; Goy-Loeper J; Jeny R; de Ligniéres B
Nouv Presse Med; 1980 Sep; 9(32):2229-32. PubMed ID: 7422517
[TBL] [Abstract][Full Text] [Related]
30. Uterotrophic effects of tamoxifen, toremifene, and raloxifene do not predict endometrial cell proliferation in the ovariectomized CD1 mouse.
Carthew P; Edwards RE; Nolan BM
Toxicol Appl Pharmacol; 1999 Jul; 158(1):24-32. PubMed ID: 10387929
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
[TBL] [Abstract][Full Text] [Related]
32. Estrogenic absorption through the skin: an experimental study.
Goisis C; Goisis F; Tammiso R
Acta Eur Fertil; 1980 Mar; 11(1):61-85. PubMed ID: 7445916
[TBL] [Abstract][Full Text] [Related]
33. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
[TBL] [Abstract][Full Text] [Related]
34. Chlropyrifos-methyl shows anti-androgenic activity without estrogenic activity in rats.
Kang HG; Jeong SH; Cho JH; Kim DG; Park JM; Cho MH
Toxicology; 2004 Jul; 199(2-3):219-30. PubMed ID: 15147795
[TBL] [Abstract][Full Text] [Related]
35. Degradation and estrogenic activity removal of 17beta-estradiol and 17alpha-ethinylestradiol by ozonation and O3/H2O2.
Maniero MG; Bila DM; Dezotti M
Sci Total Environ; 2008 Dec; 407(1):105-15. PubMed ID: 18805570
[TBL] [Abstract][Full Text] [Related]
36. Estrogenic profile of 8-azaethynylestradiol.
Rassaert CL; Richter RS; Brown RE; DiPasquale G
Steroids Lipids Res; 1972; 3(2):185-92. PubMed ID: 4657992
[No Abstract] [Full Text] [Related]
37. Estrogenic potencies of resorcylic acid lactones and 17 beta-estradiol in female rats.
Everett DJ; Perry CJ; Scott KA; Martin BW; Terry MK
J Toxicol Environ Health; 1987; 20(4):435-43. PubMed ID: 2951527
[TBL] [Abstract][Full Text] [Related]
38. The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay.
Odum J; Lefevre PA; Tittensor S; Paton D; Routledge EJ; Beresford NA; Sumpter JP; Ashby J
Regul Toxicol Pharmacol; 1997 Apr; 25(2):176-88. PubMed ID: 9185893
[TBL] [Abstract][Full Text] [Related]
39. Estrogenic effects of 17 beta-aminoestrogens assessed in uteri of rats and mice.
Lemini C; Franco Y; Avila ME; Jaimez R
Eur J Pharmacol; 2005 Mar; 510(3):235-9. PubMed ID: 15763248
[TBL] [Abstract][Full Text] [Related]
40. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin.
Liu X; Zhang F; Liu H; Burdette JE; Li Y; Overk CR; Pisha E; Yao J; van Breemen RB; Swanson SM; Bolton JL
Chem Res Toxicol; 2003 Jun; 16(6):741-9. PubMed ID: 12807357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
